Gao Y - Search Results

1

Clinical and biological significance of PIM1 kinase in osteosarcoma.

Liao Y, Feng Y, Shen J, Gao Y, Cote G, Choy E, Harmon D, Mankin H, Hornicek F, Duan Z. Liao Y, et al. Among authors: gao y. J Orthop Res. 2016 Jul;34(7):1185-94. doi: 10.1002/jor.23134. Epub 2015 Dec 31. J Orthop Res. 2016. PMID: 26687194 Free article.

2

CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcoma.

Gao Y, Feng Y, Shen JK, Lin M, Choy E, Cote GM, Harmon DC, Mankin HJ, Hornicek FJ, Duan Z. Gao Y, et al. Sci Rep. 2015 Jun 16;5:11365. doi: 10.1038/srep11365. Sci Rep. 2015. PMID: 26079799 Free PMC article.

3

NVP-TAE684 reverses multidrug resistance (MDR) in human osteosarcoma by inhibiting P-glycoprotein (PGP1) function.

Ye S, Zhang J, Shen J, Gao Y, Li Y, Choy E, Cote G, Harmon D, Mankin H, Gray NS, Hornicek FJ, Duan Z. Ye S, et al. Among authors: gao y. Br J Pharmacol. 2016 Feb;173(3):613-26. doi: 10.1111/bph.13395. Epub 2016 Jan 15. Br J Pharmacol. 2016. PMID: 26603906 Free PMC article.

4

Evaluation of P-glycoprotein (Pgp) expression in human osteosarcoma by high-throughput tissue microarray.

Gao Y, Liao Y, Shen JK, Feng Y, Choy E, Cote G, Harmon D, Mankin HJ, Hornicek FJ, Duan Z. Gao Y, et al. J Orthop Res. 2016 Sep;34(9):1606-12. doi: 10.1002/jor.23173. Epub 2016 Feb 2. J Orthop Res. 2016. PMID: 26790551 Free article.

5

miR-15b modulates multidrug resistance in human osteosarcoma in vitro and in vivo.

Duan Z, Gao Y, Shen J, Choy E, Cote G, Harmon D, Bernstein K, Lozano-Calderon S, Mankin H, Hornicek FJ. Duan Z, et al. Among authors: gao y. Mol Oncol. 2017 Feb;11(2):151-166. doi: 10.1002/1878-0261.12015. Epub 2016 Oct 24. Mol Oncol. 2017. PMID: 28145098 Free PMC article. Clinical Trial.

6

Androgen receptor is a potential novel prognostic marker and oncogenic target in osteosarcoma with dependence on CDK11.

Liao Y, Sassi S, Halvorsen S, Feng Y, Shen J, Gao Y, Cote G, Choy E, Harmon D, Mankin H, Hornicek F, Duan Z. Liao Y, et al. Among authors: gao y. Sci Rep. 2017 Mar 6;7:43941. doi: 10.1038/srep43941. Sci Rep. 2017. PMID: 28262798 Free PMC article.

7

Targeting programmed cell death ligand 1 by CRISPR/Cas9 in osteosarcoma cells.

Liao Y, Chen L, Feng Y, Shen J, Gao Y, Cote G, Choy E, Harmon D, Mankin H, Hornicek F, Duan Z. Liao Y, et al. Among authors: gao y. Oncotarget. 2017 May 2;8(18):30276-30287. doi: 10.18632/oncotarget.16326. Oncotarget. 2017. PMID: 28415820 Free PMC article.

8

Targeting CDK11 in osteosarcoma cells using the CRISPR-Cas9 system.

Feng Y, Sassi S, Shen JK, Yang X, Gao Y, Osaka E, Zhang J, Yang S, Yang C, Mankin HJ, Hornicek FJ, Duan Z. Feng Y, et al. Among authors: gao y. J Orthop Res. 2015 Feb;33(2):199-207. doi: 10.1002/jor.22745. Epub 2014 Oct 27. J Orthop Res. 2015. PMID: 25348612 Free PMC article.

9

NSC23925 prevents the emergence of multidrug resistance in ovarian cancer in vitro and in vivo.

Yang X, Feng Y, Gao Y, Shen J, Choy E, Cote G, Harmon D, Zhang Z, Mankin H, Hornicek FJ, Duan Z. Yang X, et al. Among authors: gao y. Gynecol Oncol. 2015 Apr;137(1):134-42. doi: 10.1016/j.ygyno.2015.02.002. Epub 2015 Feb 10. Gynecol Oncol. 2015. PMID: 25677062

10

Up-regulation of CD44 in the development of metastasis, recurrence and drug resistance of ovarian cancer.

Gao Y, Foster R, Yang X, Feng Y, Shen JK, Mankin HJ, Hornicek FJ, Amiji MM, Duan Z. Gao Y, et al. Oncotarget. 2015 Apr 20;6(11):9313-26. doi: 10.18632/oncotarget.3220. Oncotarget. 2015. PMID: 25823654 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46,121 results

Search Page

Filters